Related Experiment Video
Updated: Aug 20, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
[Statins]
Shu Takeda1, Yasuhiro Takeuchi
1Departmemt of Endocrinology and Metabolism, Mishuku Hospital.
Abstract:
Statins are cholesterol-lowering drugs by inhibiting HMG-CoA reductase, which is a rate limiting enzyme in the mevalonate pathway. Recently, it has been shown that the mevalonate metabolites also play a role in the regulation of bone metabolism. In particular, a couple of years ago, an exciting discovery showing that statins stimulate bone formation in rodents was published. However, there have been great controversies in effects of statins on bone in human. Here we review the role of statins in bone metabolism, mainly focusing on clinical observations.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Lipid Catabolism